Characteristics | Total (case, %) | Spontaneous clearance | Non-clearance | OR (95% CI) | p Value |
---|---|---|---|---|---|
Case (case, %) | 85 | 27, 31.8 | 58, 68.2 | – | – |
Gender (case, %) | 0.462 | ||||
Male | 45, 52.9 | 15, 55.6 | 30, 51.7 | 1.11 (0.59 to 2.08) | |
Female | 40, 47.1 | 12, 44.4 | 28, 48.3 | 0.95 (0.71 to 1.27) | |
Age, median (range) (case, %) | 32 (9–71), years | 30 (9–61), years | 34 (10–71), years | 0.160 | |
≤20 years | 19, 22.4 | 10, 37.0 | 9, 15.5 | 2.04 (1.13 to 3.69) | 0.028* |
21–40 years | 39, 45.9 | 11, 40.7 | 28, 48.3 | 0.81 (0.43 to 1.54) | 0.340 |
41–60 years | 21, 24.7 | 5, 18.5 | 16, 27.6 | 0.69 (0.30 to 1.60) | 0.267 |
≥61 years | 6, 7.0 | 1, 3.7 | 5, 8.6 | 0.51 (0.08 to 3.12) | 0.375 |
IL-28 allele frequency detected (case, %) | 64 | 24 | 40 | ||
rs10853728 CC | 36, 56.3 | 17, 70.8 | 19, 47.5 | 1.89 (0.91 to 3.91) | 0.058 |
rs12979860 CC | 53, 82.8 | 22, 91.7 | 31, 77.5 | 2.28 (0.63 to 8.32) | 0.132 |
rs8099917 TT | 53, 82.8 | 22, 91.7 | 31, 77.5 | 2.28 (0.63 to 8.32) | 0.132 |
rs12980275 AA | 53, 82.8 | 22, 91.7 | 31, 77.5 | 2.28 (0.63 to 8.32) | 0.132 |
rs4803219 CC | 55, 85.9 | 22, 91.7 | 33, 82.5 | 1.80 (0.51 to 6.37) | 0.264 |
rs4803223 AA | 47, 73.4 | 16, 66.7 | 31, 77.5 | 0.72 (0.38 to 1.38) | 0.254 |
rs8105790 TT | 54, 84.3 | 22, 91.7 | 32, 80.0 | 2.04 (0.57 to 7.33) | 0.189 |
*p<0.05 was considered to be statistically significant.
HCV, hepatitis C virus; IL, interleukin.